Additionally, individual logistic regression and ROC analyses confirmed IL-5, G-CSF, and CCL11/eotaxin-1 concentrations as the most distinguishing variables for comorbid T2DM in patients with CAD (Table S2). This evidence concerns the gene IL5 and type 2 diabetes mellitus.